Life Sciences

Schellenberg Wittmer’s Life Sciences Group is a leading practice for dispute resolution, transactional work and regulatory matters in the field of life sciences. We advise and represent companies from a variety of sectors, including pharma, biotechnology, medical devices, cosmetics, and food and beverages.

Schellenberg Wittmer’s Life Sciences Group has broad expertise in representing life sciences clients in complex international disputes and in advising on corporate and commercial matters, such as complex licensing deals, joint ventures and M&A transactions. Additionally, we provide guidance in regulatory matters and advise on data protection, compliance and investigations, e-health, software and competition law.

Litigation/Arbitration

We represent clients in litigation, arbitration and mediation proceedings over a broad range of issues, including:

• Entitlement, validity and infringement of patents, SPCs and other IP right
• Disputes arising from licensing, distribution, non-disclosure, R&D, technology transfer, manufacturing and clinical trials agreements
• Product liability and product recall matters
  

Corporate and Commercial

• R&D, licensing and development, IP acquisitions, manufacturing, distribution and option agreements
• Joint ventures
• M&A transactions
• Venture capital and private equity

Advice and Regulatory

• Clinical trials
• Pharmaceutical advertising
• Interactions with HCP
• Compliance and investigations
• Data protection, e-health and medical software
• Competition law